CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$5.32
+0.09 (+1.72%)
Open$5.25
Previous Close$5.23
Day High$5.34
Day Low$5.10
52W High$13.02
52W Low$6.13
Volume—
Avg Volume1.18M
Market Cap595.49M
P/E Ratio3.18
EPS$2.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+886.8% upside
Current
$5.32
$5.32
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 291.10M | 151.82M | 142.81M |
| Net Income | 152.28M | 25.07M | 23.58M |
| Profit Margin | 52.3% | 16.5% | 16.5% |
| EBITDA | 140.85M | 47.08M | 40.68M |
| Free Cash Flow | — | 14.58M | 22.25M |
| Rev Growth | +1,545.2% | +9.9% | -6.7% |
| Debt/Equity | 0.36 | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |